OTCBB:PMCB

Pharmacyt Biotch Stock Forecast

etoro logo Buy PMCB
*Your capital is at risk
$0.700
-0.0254 (-3.50%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of PMCB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PMCB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Pharmacyt Biotch stock price on Friday moving 10.99% between high and low
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 02, 2026 Loss -6.82%

The Pharmacyt Biotch stock price fell by -3.50% on the last day (Friday, 5th Jun 2026) from $0.725 to $0.700. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 10.99% from a day low at $0.667 to a day high of $0.741. The price has fallen in 8 of the last 10 days and is down by -12.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -51 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $0.717. A reaction back to this level may hold a second chance to get out before further falls.

PMCB Signals & Forecast

There are few to no technical positive signals at the moment. The Pharmacyt Biotch stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.771 and $0.770. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -18.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pharmacyt Biotch stock

Pharmacyt Biotch finds support from accumulated volume at $0.695 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0733 between high and low, or 10.99%. For the last week the stock has had daily average volatility of 7.42%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PMCB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Pharmacyt Biotch to open at $0.703, and during the day (based on 14 day Average True Range), to move between $0.666 and $0.734, which gives a possible trading interval of +/-$0.0671 (+/-10.07%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 10.07% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.695 (0.73%) than the resistance at $0.780 (11.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pharmacyt Biotch stock A Buy?

The Pharmacyt Biotch stock holds several negative signals and despite the positive trend, we believe Pharmacyt Biotch will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.155 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.703 ( 0.367%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PMCB Performance

Trading levels for PMCB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.776 10.84%
R2 0.748 6.84%
R1 0.731 4.37%
Price 0.700
S1 0.675 -3.63%
S2 0.657 -6.10%
S3 0.629 -10.10%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.81 15.71%
R2 0.790 12.86%
R1 0.780 11.43%
Price 0.700
S1 0.695 -0.729%
S2 0.687 -1.89%
S3 0.684 -2.29%

FAQ

What is the symbol for Pharmacyt Biotch Stock and on which exchange is it traded?
The symbol for Pharmacyt Biotch is PMCB and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Pharmacyt Biotch Stock?
The Pharmacyt Biotch stock holds several negative signals and despite the positive trend, we believe Pharmacyt Biotch will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Pharmacyt Biotch Stock?
Pharmacyt Biotch Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharmacyt Biotch Stock.

What's the current price of Pharmacyt Biotch Stock?
As of the end of day on the Jun 05, 2026, the price of an Pharmacyt Biotch (PMCB) share was $0.700.

What is the 52-week high and low for Pharmacyt Biotch Stock?
The 52-week high for Pharmacyt Biotch Stock is $1.51 and the 52-week low is $0.630.

What is the market capitalization of Pharmacyt Biotch Stock?
As of the Jun 05, 2026, the market capitalization of Pharmacyt Biotch is 4.757M.

When is the next earnings date for Pharmacyt Biotch?
The upcoming earnings date for Pharmacyt Biotch is Jul 01, 2026.
Click to get the best stock tips daily for free!
ABOUT PHARMACYT BIOTCH
Pharmacyt Biotch
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE